Hemophilia news & latest pictures from techtimes.com

Home

Hemophilia

Gene Editing Tool CRISPR Used To Correct Blood Clotting, Treat Hemophilia In Mice

The CRISPR gene editing system was used by a pioneering research aiming to treat hemophilia B. In order to eliminate the rare genetic condition, the researchers used mice in their experiments.

by Livia Rusu

Healthy Living/Wellness
FDA Greenlights Bayer's Kovaltry Therapy For Hemophilia A
by Katherine Derla
Healthy Living/Wellness
Betting Big on Gene Therapy: Pfizer Partners with Spark Therapeutics for Hemophilia Treatment
by Rhodi Lee
Healthy Living/Wellness
FDA approves Biogen's Eloctate for hemophilia A therapy
by Rhodi Lee
Healthy Living/Wellness
FDA approves hemophilia B drug Alprolix for children and adults
by Lori Sandoval
Healthy Living/Wellness
Hemophilia B drug Alprolix given the go-ahead in Canada, with U.S. approval imminent
by Tabitha Laffernis
Healthy Living/Wellness
New drugs edge hemophilia towards more effective treatment
by Pierre Dumont

Hemophilia

Gene Editing Tool CRISPR Used To Correct Blood Clotting, Treat Hemophilia In Mice

FDA Greenlights Bayer's Kovaltry Therapy For Hemophilia A

Betting Big on Gene Therapy: Pfizer Partners with Spark Therapeutics for Hemophilia Treatment

FDA approves Biogen's Eloctate for hemophilia A therapy

FDA approves hemophilia B drug Alprolix for children and adults

Hemophilia B drug Alprolix given the go-ahead in Canada, with U.S. approval imminent

New drugs edge hemophilia towards more effective treatment

Will Apple Launch a 32‑Inch iMac? 32‑Inch iMac Rumors, Apple Display Size Leaks, and Bold iMac 2026 Predictions

Remote Work Security Solutions: Behavioral Access Control Enhances Workforce Protection

Best Budget Gaming Headsets of 2026: Affordable Audio Power and Supreme Gaming Comfort

Viral Gameplay in 2026: Why Live Gaming Clips Dominate YouTube Shorts and TikTok Feeds

AI-Generated Market Forecasting: How Predictive Analytics Accelerate Strategic Planning